Commonwealth Speakers commend CIPLA Quality Chemicals

KAMPALA, January 8, 2024 – Speakers and Presiding Officers from the Commonwealth days ago visited the CIPLA Quality Chemicals Industries Ltd [CIPLA QCIL] in Luzira, Kampala where they lauded the factory for producing essential medicines.

The CIPLA QCIL plant is one of the four pharmaceutical manufacturers in Africa accredited by the World Health Organisation [WHO] to manufacture anti-retroviral drugs, anti-malarial drugs among others.

The delegation led by Deputy Speaker of the Parliament of Uganda, Thomas Tayebwa commended the Ugandan government for helping to establish the factory, saying it is tailored to solving some of Africa’s health problems.

“This is an eye opener to us that we can solve African problems using African solutions, we are very proud of Uganda” said  Ackson Tulia, Speaker, Parliament of Tanzania.

Tulia said she was sure her counterparts from other African countries will spread the ‘gospel’ on the work being done at CIPLA Quality Chemicals Industries Limited, to other nations saying “the continent is ready to accommodate products from a fellow African nation”.

She was, however, concerned that the company supplies medicines to only 15 countries, moreover in Africa and urged government to consider the western market.

“I believe that Africa can also offer solutions to the rest of the world, we would like to see you cross the borders,” Tulia said.

Tayebwa on his part, said, have the ability to influence their countries to consider importing from Uganda medicines such as Anti-retroviral drugs, anti-malarial drugs, and medicines to treat diabetes which are currently manufactured at CIPLA QCIL.

“These are the Speakers who preside over national budgets in their countries, they do oversight on how government is doing its work. We are urging them that from here they should go to their governments and ensure that medicines produced here should not be procured from Europe or Asia,” Tayebwa said.

He commended the company which he said was now both a national and continental pride.

“These are the people who saved countries like South Africa during the COVID-19 pandemic when Europe and America could not export to Africa, they stepped in and saved Africa. This plant is no longer about quality chemicals, it is a national and continental pride,” Tayebwa said.

The Chairman for CIPLA QCIL, Emmanuel Katongole, hailed Parliament for considering the plant for the Speakers’ visit, saying the company is able and ready to expand their export market.

Meanwhile, CIPLA recently completed the sale of its 51.18 percent stake in CIPLA CQCIL for a final consideration amount of US$ 25 million.
The transaction was finalised on November 14, 2023, and as a result, CQCIL will no longer be considered a subsidiary of CIPLA.
The sale was executed by CIPLA [EU] Limited, UK, and Meditab Holdings Limited, Mauritius, both wholly-owned subsidiaries of Cipla Limited.


Buy your copy of thecooperator magazine from one of our country-wide vending points or an e-copy on emag.thecooperator.news

Related Articles

Back to top button